VetClick
Menu Menu
Login

VetClick

/ News
Wednesday, 24th April 2024 | 4,327 veterinary jobs online | 122 people actively seeking work | 5,484 practices registered

Veterinary Industry News

Send us your news

Elanco Develops Flea Allergy Dermatitis Algorithm

12 years ago
2827 views

Posted
14th February, 2012 10h47


Diagram of Flea allergy algorithm Click on image to enlarge, click again to close Elanco Companion Animal Health, manufacturer of Comfortis® chewable tablets for dogs, has produced an easy to use Flea Allergy Dermatitis (FAD) algorithm to provide veterinary surgeons with step-by-step guidance on its diagnosis and treatment. Developed in conjunction with Dr Chiara Noli, DVM, Dip ECVD, a leading referral dermatologist and dermatopathologist from Northern Italy, the useful algorithm covers the many complexities and causes of pruritus. It also advises veterinary surgeons to prescribe strict oral flea control if antibacterial shampoo or lotions are used. “Canine patients with dermatological conditions including Flea Allergy Dermatitis are often prescribed topical treatments, such as shampoos, which may compromise the effectiveness of many spot-on topical flea control products,” comments Anna Jackson, veterinary manager at Elanco Companion Animal Health. “The new Flea Allergy Dermatitis algorithm takes this into account by providing veterinary surgeons with step-by-step advice on the diagnosis and treatment of Flea Allergy Dermatitis including the benefits of using oral flea control if a shampoo is administered.” Comfortis is a fast acting, chewable, beef-flavoured tablet that kills fleas and prevents flea infestations for a full month. The convenient tablet starts to kill fleas in 30 minutes and it is 100% effective in four hours. In addition, it remains fully effective despite frequent shampooing, bathing or swimming and it can be used alongside other treatments such as wormers. For a copy of the Flea Allergy Dermatitis algorithm, please contact your Elanco Companion Animal Health key account manager or email [email protected].

More from


You might be interested in...